...
首页> 外文期刊>Clinical and experimental medicine >Effects of antiviral therapy with Telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients.
【24h】

Effects of antiviral therapy with Telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients.

机译:替比夫定抗病毒治疗对HBeAg(+)慢性乙型肝炎患者外周血iNKT细胞的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

iNKT cells are relatively abundant in the liver, which suggests that they may play important roles in the clearance of invading foreign pathogens such as hepatitis B virus. In this study, we investigated the frequencies, functions and PD-1 expression of peripheral iNKT cells from HBeAg-positive chronic hepatitis B (CHB) patients during antiviral treatment with Telbivudine. Results demonstrated that as compared with the healthy donors, the peripheral iNKT cells from these patients existed at lower frequencies, displayed impaired capabilities to produce IFN-γ and expressed higher PD-1. Antiviral treatment with Telbivudine significantly increased IFN-γ production by iNKT cells, which may be associated with the decreased PD-1 expression as manifested by blocking experiments. Our study suggested that iNKT cells played an important role in the chronicity of HBV infection and antiviral therapy with Telbivudine could restore at least in part the impaired host immune response in the HBeAg-positive CHB patients.
机译:iNKT细胞在肝脏中相对丰富,这表明它们可能在清除外来病原体(如乙型肝炎病毒)的过程中发挥重要作用。在这项研究中,我们调查了替比夫定抗病毒治疗期间HBeAg阳性慢性乙型肝炎(CHB)患者外周iNKT细胞的频率,功能和PD-1表达。结果表明,与健康供体相比,这些患者的外周血iNKT细胞存在频率较低,显示出产生IFN-γ的能力受损,并表达较高的PD-1。用替比夫定抗病毒治疗可显着增加iNKT细胞产生的IFN-γ,这可能与阻断实验所证实的PD-1表达降低有关。我们的研究表明,iNKT细胞在HBV感染的慢性中起重要作用,而替比夫定的抗病毒治疗可以至少部分恢复HBeAg阳性CHB患者的宿主免疫反应受损。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号